{"id":"doi:10.1016/s0140-6736(18)31773-2","kind":"article","title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","authors":["Patrick Mahlen O'Neil","Andreas L. Birkenfeld","Barbara M. McGowan","Ofri Mosenzon","Sue D. Pedersen","Sean Wharton","Charlotte Giwercman Carson","Cecilie Heerdegen Jepsen","Maria Kabisch","John P.H. Wilding"],"author_count":10,"year":2018,"published":"2018-08-01","venue":"The Lancet","cited_by":813,"doi":"10.1016/s0140-6736(18)31773-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/s0140-6736(18)31773-2","archive_url":"https://space-kitty.com/papers/doi:10.1016/s0140-6736(18)31773-2","updated":null,"pmid":"30122305","pmcid":null,"openalex_id":"W2885588864","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}